WHO supported Solidarity trial finds remdesivir ineffective but WHO prequalifies it anyway
Even as WHO supported Solidarity Therapeutics Trial found remdesivir to be ineffective in reducing mortality and duration of hospital stay,
Read MoreEven as WHO supported Solidarity Therapeutics Trial found remdesivir to be ineffective in reducing mortality and duration of hospital stay,
Read MoreWhile India accounts for 26% of TB cases in the world, the TB notifications during the period January-June 2020 in
Read MoreWHO’s Solidarity Therapeutics Trial, the largest randomised control trial carried out in the world during the pandemic, has found that
Read MoreThe e-cigarettes makers have been following the time-tested machinations of the big tobacco companies to a tee. Using flavours is
Read MoreMerck’s Ebola vaccine, which underwent phase-3 trial during the 2014-2015 Ebola epidemic in west Africa, has shown 97.5% efficacy in
Read MoreBesides Australia, France, UK. Norway, Ireland, New Zealand and Hungary have introduced plain packaging of tobacco products. Plain packaging was
Read MoreIn a Phase IIb trail, bedaquiline drug for MDR-TB treatment was found to be cardiotoxic and hepatotoxic, and it also
Read MoreIn a “rapid communication”, WHO has informed all member States to take “immediate steps” to ensure that all injectables are
Read MoreDays after the WHO declared the end of the May 8 Ebola outbreak in the Democratic Republic of the Congo, a
Read MoreThe polio endgame is proving to be much more challenging with 28 children becoming paralysed by the circulating type 2 vaccine-derived
Read MoreBy Susie Neilson Changes made to an international breastfeeding resolution under pressure from the Trump administration are more extensive than
Read MoreSanofi has launched in India its quadrivalent influenza vaccine (FluQuadri) containing two A virus strains — H1N1 and H3N2 — and two
Read MoreStarting September 2018, all tobacco products will have scarier pictorial warnings and new grimmer written messages. And for the first
Read More